Abiomed Inc (NASDAQ:ABMD)
During the Trading Day
| 26.31 |  +0.02 / +0.08% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 26.31 |  0.00 / 0.00% |
Volume: 3.5K |
Latest ABMD News | Press Releases
No recent news for Abiomed Inc.
Today’s Trading
| Previous close | 26.29 |
| Today’s open | 26.21 |
| Day’s range | 25.72 - 26.33 |
| Volume | 447,543 |
| Average volume (3 months) | 324,005 |
| Market cap | $1.1B |
| Dividend yield | -- |
Data as of 4:00pm ET, 07/28/2014
Growth & Valuation
| Earnings growth (last year) | -51.35% |
| Earnings growth (this year) | +46.30% |
| Earnings growth (next 5 years) | +21.50% |
| Revenue growth (last year) | +16.14% |
| P/E ratio | 146.2 |
| Price/Sales | 5.58 |
| Price/Book | 6.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRNXTornier NV | -0.03 | -0.14% |
| ABAXAbaxis Inc | +1.57 | +3.42% |
| OMCLOmnicell Inc | -0.09 | -0.33% |
| ICUIICU Medical Inc | -0.21 | -0.35% |
Data as of 4:00pm ET, 07/28/2014
Financials
| Next reporting date | July 31, 2014 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $183.6M |
| Annual profit (last year) | $7.4M |
| Net profit margin | 4.00% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Minogue |
Chief Operating Officer David M. Weber |
Corporate headquarters Danvers, Massachusetts |
Forecasts
.
